A. Tagliaferri

发表

ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients: A Study from the Italian Association of Hemophilia Centers

M. Franchini, C. Santoro, G. Barillari, 2021, Seminars in Thrombosis and Hemostasis.

Blood Group O Protects against Inhibitor Development in Severe Hemophilia A Patients

G. Castaldo, M. Franchini, P. Pedrazzi, 2016, Seminars in Thrombosis and Hemostasis.

nonsevere hemophilia A ) mutation and risk of inhibitor development in F8 Factor VIII gene (

J. Astermark, R. Keenan, J. Oldenburg, 2014 .

GENERAL INTRODUCTION AND OUTLINE OF THE THESIS

J. Astermark, R. Keenan, J. Oldenburg, 2012 .

THROMBOSIS AND HEMOSTASIS Factor VIII gene ( F 8 ) mutation and risk of inhibitor development in nonsevere hemophilia A

J. Astermark, R. Keenan, J. Oldenburg, 2013 .

Clinical use and the Italian demand for activated prothrombin complex and activated recombinant factor VII concentrates.

M. Franchini, C. Ruosi, G. Di Minno, 2013, Blood transfusion = Trasfusione del sangue.

Prophylaxis in Children with Hemophilia: Evidence-Based Achievements, Old and New Challenges

M. Franchini, A. Coppola, A. Tagliaferri, 2012, Seminars in Thrombosis & Hemostasis.

Searching for the role of primary prophylaxis in preventing inhibitor development in hemophilia A

M. Franchini, A. Coppola, A. Tagliaferri, 2012, Journal of thrombosis and haemostasis : JTH.

Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A

P. Mannucci, E. Santagostino, P. Mannucci, 2012, Journal of thrombosis and haemostasis : JTH.

Successful immune tolerance induction with factor VIII/von Willebrand factor concentrate in an elderly patient with severe haemophilia A and a high responder inhibitor.

M. Franchini, F. Riccardi, A. Tagliaferri, 2010, Blood transfusion = Trasfusione del sangue.

Enabling normal psychophysical development in children with hemophilia: the choice for prophylaxis

M. Franchini, A. Coppola, A. Tagliaferri, 2010 .

Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies

M. Franchini, C. Santoro, G. Di Minno, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Forum on: the role of recombinant factor VIII in children with severe haemophilia A

M. Franchini, C. Santoro, A. Coppola, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Efficacy and inhibitor development in previously treated patients with haemophilia A switched to a B domain‐deleted recombinant factor VIII

M. Morfini, E. Santagostino, P. Mannucci, 2004, British journal of haematology.

Characterization of a novel mutation in the F8 promoter region associated with mild hemophilia A and resistance to DDAVP therapy

M. Franchini, T. Neri, F. Riccardi, 2009, Journal of thrombosis and haemostasis : JTH.

The Natural History of Hepatitis C Virus Infection in Hemophiliacs

M. Franchini, A. Tagliaferri, G. Gandini, 2001, Hematology.

The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders.

G. Lippi, M. Franchini, A. Tagliaferri, 2001, Blood.

Risk of venous thromboembolism and stroke associated with oral contraceptives. Role of congenital thrombophilias.

F. Bernardi, U. Scoditti, A. Tagliaferri, 1996, Recenti progressi in medicina.

Computer Assisted Anticoagulant Therapy

A. Tagliaferri, M. Lombardi, R. Quintavalla, 2003, Pathophysiology of Haemostasis and Thrombosis.

Cancers in Patients with von Willebrand Disease: A Survey from the Italian Association of Haemophilia Centres

M. Franchini, C. Santoro, G. Castaman, 2015, Seminars in Thrombosis & Hemostasis.

Haemophilia at various stages of life: design of new therapeutic strategies through an interactive course--the Kogeniale project.

A. Iorio, M. Morfini, E. Santagostino, 2013, Blood transfusion = Trasfusione del sangue.

Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders

M. Franchini, A. Coppola, A. Tagliaferri, 2020, Seminars in Thrombosis and Hemostasis.

The management of cardiovascular diseases in patients with hemophilia.

M. Franchini, A. Coppola, A. Tagliaferri, 2010, Seminars in thrombosis and hemostasis.

Predictors of inhibitor eradication by primary immune tolerance induction in severe haemophilia A with high responding inhibitors

M. Margaglione, E. Santagostino, P. Mannucci, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Pain assessment and management in Italian Haemophilia Centres.

M. Margaglione, M. Franchini, I. Nichele, 2020, Blood transfusion = Trasfusione del sangue.

Central nervous system bleeding in patients with rare bleeding disorders

D. Consonni, A. Iorio, G. Castaman, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Current Choices and Management of Treatment in Persons with Severe Hemophilia A without Inhibitors: A Mini-Delphi Consensus

M. Franchini, C. Santoro, A. Coppola, 2022, Journal of clinical medicine.

Severe bleeding in a patient with factor XIII deficiency and COVID‐19

A. Coppola, A. Tagliaferri, E. Michieletti, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.

G. Lippi, M. Franchini, A. Tagliaferri, 2003, Haematologica.

The management of hemophilia in elderly patients

M. Franchini, P. Mannucci, A. Tagliaferri, 2007, Clinical interventions in aging.

Awaiting evidence‐based recommendations on prophylaxis in adult patients

A. Tagliaferri, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Anaphylaxis in patients with congenital bleeding disorders and inhibitors

G. Lippi, M. Montagnana, M. Franchini, 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Prophylaxis in people with haemophilia

M. Franchini, A. Coppola, A. Tagliaferri, 2009, Thrombosis and Haemostasis.

Environmental risk factors for inhibitor development in children with haemophilia A: a case–control study

P. Mannucci, E. Santagostino, A. Tagliaferri, 2005, British journal of haematology.

Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease

M. Morfini, M. Franchini, G. Barillari, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients.

P. Mannucci, M. Morfini, M. Franchini, 2007, Haematologica.

Interferon and ribavirin in HIV‐negative haemophiliacs with chronic hepatitis C who were nonresponders to a previous interferon treatment

G. Aprili, M. Franchini, A. Tagliaferri, 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

Prevalence of Infection with the Hepatitis C Virus among Italian Hemophiliacs before and after the Introduction of Virally Inactivated Clotting Factor Concentrates: A Retrospective Evaluation

P. Mannucci, M. Morfini, N. Ciavarella, 1994, Vox sanguinis.

Clinical Efficacy and Determinants of Response to Treatment with Desmopressin in Mild Hemophilia A

M. Franchini, F. Riccardi, A. Tagliaferri, 2013, Seminars in Thrombosis & Hemostasis.

Hemophilia and cancer: a new challenge for hemophilia centers.

G. Lippi, M. Montagnana, M. Franchini, 2009, Cancer treatment reviews.

Clinical pharmacology of a new low molecular weight heparin (Alfa LMWH-Fluxum).

E. Dall’aglio, M. Pini, A. Tagliaferri, 1988, International angiology : a journal of the International Union of Angiology.

Hemophilia severity score system: validation from an Italian Regional Hemophilia Reference Center

M. Franchini, A. Tagliaferri, G. Rivolta, 2009, Journal of thrombosis and haemostasis : JTH.

Intron factor VIII gene inversion in a population of Italian hemophilia A patients.

T. Neri, F. Riccardi, A. Tagliaferri, 2002, Blood.

The use of central venous catheters in haemophilia patients

M. Franchini, A. Tagliaferri, G. Izzi, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Inhibitors in Hemophilia B

C. Santoro, G. Castaman, A. Ferretti, 2018, Seminars in Thrombosis and Hemostasis.

FEIBA versus NovoSeven in Hemophilia Patients with Inhibitors

G. Lippi, M. Franchini, A. Coppola, 2013, Seminars in Thrombosis & Hemostasis.

Absence of thromboembolic complications in patients with hereditary bleeding disorders undergoing major orthopaedic surgery without antithrombotic prophylaxis.

M. Franchini, A. Tagliaferri, G. Gandini, 2004, Thrombosis and haemostasis.

LRP1/CD91 is up‐regulated in monocytes from patients with haemophilia A: a single‐centre analysis

M. Franchini, S. Crestani, F. Riccardi, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Systematic Review of the Role of FVIII Concentrates in Inhibitor Development in Previously Untreated Patients with Severe Hemophilia A: A 2013 Update

M. Morfini, E. Santagostino, M. Franchini, 2013, Seminars in Thrombosis & Hemostasis.

Cryptic 13q34 and 4q35.2 Deletions in an Italian Family

L. Garavelli, T. Neri, F. Riccardi, 2015, Cytogenetic and Genome Research.

[Homan's sign revisited: is the clinical diagnosis of deep venous thrombosis reliable?].

M. Pini, A. Tagliaferri, C. Pattacini, 1984, Recenti progressi in medicina.

The natural history of mild haemophilia: a 30‐year single centre experience

M. Franchini, F. Riccardi, A. Tagliaferri, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Assessment of Hemophilic Arthropathy by Ultrasound: Where Do We Stand?

P. Ambrosino, A. Coppola, A. Tagliaferri, 2016, Seminars in Thrombosis & Hemostasis.

Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US)

M. Morfini, E. Santagostino, A. Tagliafico, 2013, Thrombosis and Haemostasis.

Secondary prophylaxis in adolescent and adult haemophiliacs.

A. Tagliaferri, G. Rivolta, C. Di Perna, 2008, Blood transfusion = Trasfusione del sangue.

Cost‐effectiveness analysis of late prophylaxis vs. on‐demand treatment for severe haemophilia A in Italy

M. Toumi, A. Coppola, A. Tagliaferri, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Primary prophylaxis and early secondary prophylaxis in children

M. Franchini, A. Coppola, A. Tagliaferri, 2017 .

Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study

C. Santoro, A. Coppola, E. Zanon, 2015, Thrombosis and Haemostasis.

Effects of secondary prophylaxis started in adolescent and adult haemophiliacs

P. Mannucci, M. Franchini, C. Santoro, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians

M. Franchini, A. Coppola, A. Tagliaferri, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: the SHAPE Study.

G. Di Minno, M. Marietta, R. Santoro, 2019, Blood transfusion = Trasfusione del sangue.

Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy

P. Mannucci, E. Santagostino, M. Franchini, 2009, Journal of thrombosis and haemostasis : JTH.

Improving assessment and management of pain in hemophilia: an Italian Delphi consensus statement.

C. Mattia, C. Santoro, G. Di Minno, 2021, Blood reviews.

A web‐based registry of inherited bleeding disorders in the region of Emilia‐Romagna: results at three and a half years

M. Marietta, A. Tagliaferri, G. Rivolta, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

A prospective registry of European haemophilia B patients receiving nonacog alfa, recombinant human factor IX, for usual use

M. Makris, A. Hassoun, A. Tagliaferri, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Dental procedures in adult patients with hereditary bleeding disorders: 10 years experience in three Italian Hemophilia Centers

M. Franchini, A. Tagliaferri, G. Gandini, 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

IDEAL study: A real‐world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX‐FP) in patients with haemophilia B in Italy

M. Margaglione, A. Tosetto, C. Santoro, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Experience of secondary prophylaxis in 20 adolescent and adult Italian hemophiliacs

M. Franchini, A. Tagliaferri, G. Rivolta, 2006, Thrombosis and Haemostasis.

Identification of the Profile of the Patients with Hemophilia B Eligible for Treatment with Nonacog Alfa Once-Weekly

M. Morfini, C. Santoro, R. De Cristofaro, 2020 .

Models for institutional and professional accreditation of haemophilia centres in Italy

M. Morfini, E. Santagostino, P. Mannucci, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Cumulative inhibitor incidence in previously untreated patients with severe hemophilia A treated with plasma-derived versus recombinant factor VIII concentrates: a critical systematic review.

M. Franchini, A. Tagliaferri, C. Mengoli, 2012, Critical reviews in oncology/hematology.

Inhibitor development and mortality in non‐severe hemophilia A

J. Bom, R. Schwaab, A. Tagliaferri, 2015, Journal of thrombosis and haemostasis : JTH.

Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors

A. Iorio, P. Mannucci, G. Barillari, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC Registry

A. Frigo, A. Tosetto, C. Santoro, 2022, Journal of clinical medicine.

Impact of Early Factor VIII Exposure, Prophylaxis and Prenatal/Perinatal Events on Inhibitor Risk in Children with Hemophilia A: A Case-Control Study.

P. Mannucci, E. Santagostino, M. Luciani, 2004 .

Emerging Issues on Comprehensive Hemophilia Care: Preventing, Identifying, and Monitoring Age-Related Comorbidities

M. Franchini, C. Santoro, A. Coppola, 2013, Seminars in Thrombosis & Hemostasis.

Optimising prophylaxis outcomes and costs in haemophilia patients switching to recombinant FVIII-Fc: a single-centre real-world experience.

A. Coppola, F. Riccardi, A. Tagliaferri, 2019, Blood transfusion = Trasfusione del sangue.

Mortality and causes of death in Italian persons with haemophilia, 1990–2007

M. Morfini, E. Santagostino, M. Franchini, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype

M. Margaglione, E. Grandone, F. Torricelli, 2008, Haematologica.

Safety and efficacy of nonacog alfa for the treatment of haemophilia B in children younger than 6 years of age in a routine clinical care setting: the EUREKIX registry study

E. Santagostino, P. Giordano, A. Tagliaferri, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Association between haemophilia and inherited thrombophilia: a single centre survey

M. Franchini, F. Riccardi, A. Tagliaferri, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Immune tolerance induction with moroctocog‐alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high‐titre inhibitors: Data from REF.IT Registry

E. Santagostino, C. Santoro, A. Coppola, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

A retrospective study to describe the incidence of moderate to severe allergic reactions to factor IX in subjects with haemophilia B

M. Recht, A. Tagliaferri, H. Pollmann, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Alloantibodies and Congenital Bleeding Disorders: New Insights in the Pathogenesis and Management

M. Franchini, C. Santoro, A. Coppola, 2018, Seminars in Thrombosis and Hemostasis.

A web‐based clinical record ‘xl’Emofilia®’ for outpatients with haemophilia and allied disorders in the Region of Emilia‐Romagna: features and pilot use

F. Riccardi, A. Tagliaferri, G. Rivolta, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series

A. Iorio, T. Lambert, M. Makris, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers

M. Morfini, M. Franchini, C. Santoro, 2012, Journal of thrombosis and haemostasis : JTH.

Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age‐matched controls

A. Iorio, A. Nobili, E. Santagostino, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Spectrum of F8 gene mutations in haemophilia A patients from a region of Italy: identification of 23 new mutations

M. Volta, P. Pedrazzi, M. Savi, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

The effect of carriers’ reproductive choices and pregnancy history on sporadic severe haemophilia: A 20‐year retrospective study through a regional registry

A. Coppola, F. Riccardi, A. Tagliaferri, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

The increased demand for plasma-derived factor VIII in Italy between 2011 and 2014 is attributable to treatment of adult patients rather than paediatric or previously unexposed patients with severe haemophilia A.

M. Morfini, E. Santagostino, G. Di Minno, 2017, Blood transfusion = Trasfusione del sangue.

Controversies in Inherited Bleeding Disorders

M. Franchini, A. Coppola, A. Tagliaferri, 2016, Seminars in Thrombosis & Hemostasis.

Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project

M. Clerici, E. Santagostino, R. Mazzucchelli, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

A skewed lyonization phenomenon as cause of hemophilia A in a female patient.

A. Tagliaferri, D. Caprino, P. Mori, 1995, Blood.

Update on chronic hepatitis C in hemophiliacs.

G. Aprili, M. Franchini, A. Tagliaferri, 2002, Haematologica.

Very high risk of intracranial hemorrhage and severe outcomes in adult patients with mild hemophilia: Sub-analysis of the EMO.REC Registry.

C. Santoro, S. Pasca, E. Zanon, 2022, Thrombosis research.

F7 gene variants modulate protein levels in a large cohort of patients with factor VII deficiency

F. Riccardi, A. Tagliaferri, G. Rivolta, 2017, Thrombosis and Haemostasis.

Comorbidities in persons with haemophilia aged 60 years or more compared with age‐matched people from the general population

A. Iorio, E. Santagostino, P. Mannucci, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders: dosing, pharmacokinetics and clinical efficacy.

M. Morfini, E. Santagostino, P. Mannucci, 2006, Haematologica.

Accuracy of strain-gauge plethysmography as a diagnostic test in clinically suspected deep venous thrombosis.

M. Pini, A. Tagliaferri, T. Poli, 1984, Thrombosis research.

Low Molecular Weight Heparin versus Warfarin in the Prevention of Recurrences after Deep Vein Thrombosis

M. Pini, A. Tagliaferri, R. Quintavalla, 1994, Thrombosis and Haemostasis.

Subcutaneous vs Intravenous Heparin in the Treatment of Deep Venous Thrombosis – A Randomized Clinical Trial

M. Pini, A. Tagliaferri, R. Quintavalla, 1990, Thrombosis and Haemostasis.

Comparison of quality of life, and emotional and functional profiles in older people with and without severe haemophilia

A. Iorio, E. Santagostino, P. Mannucci, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Invasive procedures and minor surgery in factor VII deficiency

G. Mariani, A. Tagliaferri, G. Auerswald, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Low molecular weight heparin (Alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures.

M. Pini, A. Tagliaferri, C. Manotti, 1989, International Angiology.

Combined use of strain-gauge plethysmography and latex D-dimer test in clinically suspected deep venous thrombosis

M. Pini, A. Tagliaferri, R. Quintavalla, 1993 .

Low-oestrogen oral contraceptives as a major risk factor for cerebral venous and sinus thrombosis: evidence from a clinical series

G. Buccino, U. Scoditti, A. Tagliaferri, 1999, The Italian Journal of Neurological Sciences.

A novel heterozygous missense mutation (His127Arg) in a family with inherited cross-reacting material positive factor XI deficiency

F. Rodeghiero, G. Castaman, A. Tagliaferri, 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

The expanding role of prophylaxis with recombinant activated factor VII.

M. Franchini, A. Tagliaferri, 2013, Blood transfusion = Trasfusione del sangue.

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

J. Esser, G. Tiscia, M. N. D. Minno, 2012, Journal of thrombosis and haemostasis : JTH.

Analysis of the structural effects of four novel and a previously known mutations causing factor XI deficiency

V. Rimoldi, S. Duga, G. Castaman, 2009, Thrombosis and Haemostasis.

Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers: a reply to a rebuttal

M. Franchini, A. Tagliaferri, 2012 .

Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey

M. Margaglione, M. Morfini, E. Santagostino, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders.

M. Franchini, A. Tagliaferri, G. Gandini, 2001, Blood.

A novel heterozygous missense mutation (His127Arg) in a family with inherited cross-reacting material positive factor XI deficiency

F. Rodeghiero, G. Castaman, A. Tagliaferri, 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Management of coronary artery disease in a severe haemophilia patient with high titre inhibitor and anaphylaxis

M. Franchini, A. Tagliaferri, G. Rivolta, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.

G. Lippi, M. Franchini, A. Tagliaferri, 2003, Haematologica.

Old and New Challenges in Hemophilia Management

M. Franchini, A. Coppola, A. Tagliaferri, 2013, Seminars in Thrombosis & Hemostasis.

Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A.

J. Astermark, R. Keenan, V. Jiménez‐Yuste, 2013, Blood.

Six-Year, Real-World Use of Prophylaxis with Recombinant Factor IX–Albumin Fusion Protein (rIX-FP) in Persons with Hemophilia B: A Single-Center Retrospective–Prospective Study

F. Riccardi, A. Tagliaferri, G. Rivolta, 2024, Journal of Clinical Medicine.

[Hypercoagulability during pregnancy: evidences for a thrombophilic state].

A. Tagliaferri, M. Torella, M. Maiello, 2006, Minerva ginecologica.

Controversies in Inherited Bleeding Disorders

M. Franchini, A. Coppola, A. Tagliaferri, 2016, Seminars in Thrombosis & Hemostasis.

Preface Controversies in Inherited Bleeding Disorders

M. Franchini, A. Tagliaferri, 2016 .